维普中文期刊产品整合服务
47篇 您的检索式:作者名="FOSS F M"
    题名 作者 年代 出处 被引量
1Enhancement of protein adsorption induced by surface roughness 显示文摘RechendorffK Hovgaard M B Foss M Zhdanov V P Besenbaeher F 2006Langmuir2006,22,10:1
2Current and emerging treatment strategies for cutaneous t-cell lymphoma显示文摘Lansigan F Foss F M 2010Drugs2010,70,3:1
3Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo controlled,intravenous,ascending dose, pharmacokinetic study显示文摘 M F O'CONNOR C S YUAN 1997J Clin Pharmacol1997,37,:1
4Methylnaltrexone prevents morphine induced delay in oral cecal transit time without affecting analgesia: a double blind randomized placebo controlled trial显示文摘 J F FOSS M O'CONNOR 1996Clin Pharmacol Ther1996,59,:1
5Effects of enteric coated methylnaltrexone in preventing opioid induced delay in oral cecal transit time显示文摘 J F FOSS M O'CONNOR 2000Clin Pharmacol Ther2000,67,:1
6Isolation by time and habitat and coexistence of distinct host races of the common cuckoo显示文摘M(o)ller AP Antonov A Stokke BG Foss(o)y F Moksnes A R(o)skaft E Takasu F 0,,:1
7Methylnaltrexone for reversal of constipation due to chronic methadone use显示文摘 J F FOSS M O CONNOR 2000JAMA2000,283,:1
8Biological corre-lates of acute hypersensitivity events with DAB (389)IL-2 (denileukin diftitox,ONTAK) in cutaneous T-cell lymphoma:decreased frequency and severity withsteroid premedication显示文摘 Bacha P Osann K E 2001Clin Lymphoma2001,1,4:1
9The vanderbilt professional nursing practice program, part : intergrating a professional advancement evaluation system显示文摘O' Hara N F Duvanieh M Foss J 2003J Nurs Adm2003,33,10:1
10Phase I study of the pharmacokinetics of a radioimmunoconjugate,90 Y - T101 , in patients with CD5 - expressing leukemia and lymphoma 显示文摘FOSS F M RAUBITSCHECK A MULSHINE J L 1998Clin Cancer Res1998,4,11:1
11Influence of nanoscale surface topography on protein adsorption and cellular response 显示文摘Lord MS Foss M Besenbacher F 2010Nano Today2010,5,1:1
12Biological correlates of acute hypersensitivity events with DAB (389) IL-2 (denileukin diftitox, ONTAK) in eutaneous T- cell lymphoma:decreased frequency and severity with steroid premedieation显示文摘Foss F M Baeha P Osann K E 2001Clin Lymphoma2001,1,4:1
13A phase II trial of Belinostat(PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma显示文摘FOSS F ADVANI R DUVIC M 2015Br J Haematol2015,168,6:1
14Immunologic mechanisms of antitumor activity显示文摘Foss F M 2002Semin Oncol2002,29,7:1
15Coevolution in action:disruptive selection on egg colour in an avian brood parasite and its host显示文摘Yang C Liang W Cai Y Shi S Takasu F M(o)ller AP Antonov A Foss(o)y F Moksnes A R(o)skaft E Stokke BG 0,,:1
16Physicochemical Hydrodynamics显示文摘LEVICH V G POTTER M C FOSS J F 1962Prentice Hall Inc Englewood Cliffs NJ1962,1962,:1
17A Phase II trial of Belinostat(PXD101)in patients with relapsed or refractory peripheral orcutaneous T-cell lymphoma显示文摘Foss F Advani R Duvic M 2015Br J Haematol2015,168,6:1
18Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia 显示文摘Morrison D F Foss D L Murtaugh M P 2000Infect Immun2000,68,8:1
19Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia显示文摘LIMA FM O FIGUEIREDO G L FOSS F M C etal 2010Braz J Med Biol Res2010,43,6:1
20Organocatalytic Dakin oxidation by nucleophilic flavin catalysts显示文摘CHEN S HOSSAIN M S FOSS F W 2012Organic Letters2012,14,11:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费